We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.36%
AUM
$208M
AUM Growth
+$17.1M
Cap. Flow
-$1.57M
Cap. Flow %
-0.76%
Top 10 Hldgs %
15.26%
Holding
148
New
6
Increased
34
Reduced
101
Closed
3

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$716K
2
NFLX icon
Netflix
NFLX
+$435K
3
GL icon
Globe Life
GL
+$364K
4
NKE icon
Nike
NKE
+$282K
5
PCAR icon
PACCAR
PCAR
+$281K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$460K
2
VZ icon
Verizon
VZ
+$372K
3
NEE icon
NextEra Energy
NEE
+$316K
4
ADM icon
Archer Daniels Midland
ADM
+$280K
5
DHR icon
Danaher
DHR
+$266K

Sector Composition

Rank Sector Weight
1 Technology 19.88%
2 Healthcare 16.87%
3 Industrials 15.7%
4 Consumer Discretionary 12.93%
5 Consumer Staples 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
101
Freeport-McMoran
FCX
$95.5B
$688K 0.33%
16,152
+3,028
+23% +$112K
VLO icon
102
Valero Energy
VLO
$87.2B
$659K 0.32%
5,068
+25
+0.5% +$3.18K
CI icon
103
Cigna
CI
$72.7B
$649K 0.31%
2,167
+44
+2% +$12.9K
ED icon
104
Consolidated Edison
ED
$40.2B
$639K 0.31%
7,020
-1,404
-17% -$125K
MDLZ icon
105
Mondelez International
MDLZ
$80.1B
$598K 0.29%
8,255
-105
-1% -$7.2K
IBM icon
106
IBM
IBM
$220B
$584K 0.28%
3,571
-19
-0.5% -$2.87K
ITT icon
107
ITT
ITT
$19.2B
$561K 0.27%
4,705
+725
+18% +$76.2K
KMB icon
108
Kimberly-Clark
KMB
$36.1B
$537K 0.26%
4,422
-700
-14% -$84.6K
MRSH
109
Marsh
MRSH
$92.2B
$536K 0.26%
2,827
-3
-0.1% -$580
MDT icon
110
Medtronic
MDT
$110B
$534K 0.26%
6,486
-150
-2% -$11.4K
MS icon
111
Morgan Stanley
MS
$336B
$517K 0.25%
5,548
+306
+6% +$24.5K
CRM icon
112
Salesforce
CRM
$153B
$495K 0.24%
1,881
-110
-6% -$24.9K
CRL icon
113
Charles River Laboratories
CRL
$12.8B
$490K 0.24%
2,073
-1,102
-35% -$217K
MRK icon
114
Merck
MRK
$317B
$488K 0.23%
4,476
+250
+6% +$25.9K
MMM icon
115
3M
MMM
$93.2B
$464K 0.22%
5,071
-5,728
-53% -$460K
MA icon
116
Mastercard
MA
$505B
$432K 0.21%
1,013
-2
-0.2% -$803
CCK icon
117
Crown Holdings
CCK
$13.2B
$419K 0.2%
4,552
-13
-0.3% -$1.1K
MTD icon
118
Mettler-Toledo International
MTD
$28.5B
$394K 0.19%
325
-69
-18% -$74.6K
C icon
119
Citigroup
C
$224B
$367K 0.18%
7,135
+1,368
+24% +$60.6K
CHE icon
120
Chemed
CHE
$7.18B
$331K 0.16%
566
AA icon
121
Alcoa
AA
$12.5B
$305K 0.15%
8,969
-6,685
-43% -$181K
SHEL icon
122
Shell
SHEL
$248B
$298K 0.14%
4,529
RIO icon
123
Rio Tinto
RIO
$162B
$290K 0.14%
+3,900
New +$262K
GGG icon
124
Graco
GGG
$13.5B
$287K 0.14%
3,310
GILD icon
125
Gilead Sciences
GILD
$162B
$286K 0.14%
3,536
-48
-1% -$3.73K

Similar funds

Eads & Heald Wealth Management's Q4 2023 Portfolio in Review

As of Q4 2023, Eads & Heald Wealth Management held 148 positions worth $208M, up 9% from $191M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2023 filing shows 6 new, 34 increased, 101 reduced and 3 closed positions. Its largest new stake was Rio Tinto: 3,900 shares worth $290K. The largest sale was 3M, an estimated $460K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2023 buy was Rio Tinto: 3,900 shares worth $290K.
  • Eads & Heald Wealth Management added most to Adobe in Q4 2023, an estimated $716K increase.
  • Eads & Heald Wealth Management's biggest Q4 2023 reduction was 3M, cutting an estimated $460K.
  • Eads & Heald Wealth Management fully exited Conagra Brands in Q4 2023, selling an estimated $258K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $208M portfolio in Q4 2023.
  • Eads & Heald Wealth Management opened 6 new positions and closed 3 in Q4 2023.
  • Eads & Heald Wealth Management's portfolio value rose 9% quarter-over-quarter to $208M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.